Canada Approves First Bivalent COVID-19 Booster for Children Ages 5 to 11

Translator

Editor

Laila Afifa

Sabtu, 10 Desember 2022 12:46 WIB

TEMPO.CO, Ottawa - Health Canada on Friday, Dec. 9, authorized the Pfizer-BioNTech Comirnaty Omicron BA.4/BA.5 bivalent-adapted booster for use in children 5 to 11 years of age.

This is the first bivalent COVID-19 booster authorized for use in this age group that targets the original COVID-19 strain and the Omicron BA.4/BA.5 subvariants, Health Canada said in a press release.

According to the release, Health Canada previously authorized this bivalent booster for use in individuals 12 years of age and older on Oct. 7, 2022. While the formulation for children 5 to 11 years of age is the same, the dose is one-third of that authorized for individuals 12 years of age and older.

The release said that after a thorough and independent scientific review of the evidence, Health Canada has determined that the Pfizer-BioNTech Comirnaty Omicron BA.4/BA.5 bivalent-adapted booster vaccine for children 5 to 11 years of age is safe and effective and that its benefits outweigh any potential risks.

Vaccination continues to be one of the most effective tools to protect families and communities against COVID-19, Health Canada said.

Xinhua

Click here to get the latest news updates from Tempo in Google News

Indonesian Researchers in Spain Discover Antibodies to Avert COVID-19 Virus

9 hari lalu

Indonesian Researchers in Spain Discover Antibodies to Avert COVID-19 Virus

BRIN researcher Yudhi Nugraha and his team in Madrid, Spain, discovered antibodies called Spikebodies that can prevent the COVID-19 virus, SARS-CoV-2.

After COVID, WHO Defines Disease Spread 'Through Air'

12 hari lalu

After COVID, WHO Defines Disease Spread 'Through Air'

The WHO and 500 experts have agreed on what it means for a disease to spread through the air to avoid the confusion early in the COVID-19 pandemic.

House Member Highlights Lack of Govt Appreciation for Health Workers Amid Dismissal Case in NTT

13 hari lalu

House Member Highlights Lack of Govt Appreciation for Health Workers Amid Dismissal Case in NTT

DPR Commission IX member highlighted the case of the dismissal of 249 non-civil servants health workers in Manggarai, East Nusa Tenggara (NTT).

Tourism Minister Sandiaga Uno to Speak on Indonesian Tourism Post-Pandemic at UNGA Sustainability Week

22 hari lalu

Tourism Minister Sandiaga Uno to Speak on Indonesian Tourism Post-Pandemic at UNGA Sustainability Week

Sandiaga Uno will speak at the UN General Assembly in New York about quality and sustainable tourism.

Eid al-Fitr; Epidemiologist Warns of Hike in Singapore Flu Infection

25 hari lalu

Eid al-Fitr; Epidemiologist Warns of Hike in Singapore Flu Infection

The incidence of Singapore flu in Indonesia, as of March 2024, stands at a staggering 5,461 cases, according to the Health Ministry.

OJK Announces End of COVID-19 Banking Credit Relaxation

30 hari lalu

OJK Announces End of COVID-19 Banking Credit Relaxation

The Financial Services Authority (OJK) announced that the Covid-19 banking credit relaxation stimulus has ended on March 31, 2024.

Indonesia's Aviation Sector to Recover 100% in 2024 Post COVID-19 Pandemic

54 hari lalu

Indonesia's Aviation Sector to Recover 100% in 2024 Post COVID-19 Pandemic

The recovery in the aviation sector post-COVID-19 pandemic has reached 83 percent.

How India's COVID Lockdowns Impacted Menstrual Health

24 Februari 2024

How India's COVID Lockdowns Impacted Menstrual Health

Limited access to period products during India's COVID lockdown highlighted how far public health initiatives have to go when it comes to menstruation